Lupus

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barkauskaite, V.
Right arrow Articles by Nyberg, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barkauskaite, V.
Right arrow Articles by Nyberg, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Lupus, Vol. 16, No. 10, 794-802 (2007)
DOI: 10.1177/0961203307081895

Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus

V. Barkauskaite

Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, vilija.barkauskaite{at}ki.se

M. Ek

Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

K. Popovic

Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden

H.E. Harris

Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

M. Wahren-Herlenius

Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

F. Nyberg

Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden

HMGB1 is a pro-inflammatory cytokine that together with TNF-{alpha} and IL-1ß is involved in the pathogenesis of spontaneously occurring skin lesions in lupus erythematosus. The purpose of the present study was to explore the sequence of events in HMGB1, TNF-{alpha} and IL-1ß expression under development and resolution of experimentally induced CLE lesions. The study involved investigation of 38 serial skin biopsies acquired from photoprovoked skin lesions of nine CLE patients, using immunohistochemical staining of tissue sections. In biopsies from the clinically most active phase of skin involvement extracellular, secreted HMGB1 and increased cytoplasmic HMGB1 were found, as compared with the late and fading lesions or non-lesional skin. Besides HMGB1, increased expression of TNF-{alpha} and IL-1ß was observed in dermal infiltrates of the induced CLE lesions. These cytokines were however not upregulated in all lesions, and increased expression of IL-1ß was seen predominantly in late biopsies.

In conclusion, extracellular and cytoplasmic HMGB1 coincides with the clinically most active phase of photoinduced lesions of cutaneous lupus, and suggests that HMGB1 is an important factor in the inflammatory autoimmune process of CLE. HMGB1 can induce expression of TNF-{alpha} and IL-1ß, and formation of a pro-inflammatory loop between HMGB1, TNF-{alpha}, and IL-1ß may be responsible for the prolonged and sustained inflammation in CLE. Lupus (2007) 16, 794—802.

Key Words: lupus • skin • HMGB1 • TNF-{alpha} • IL-1ß • photoprovocation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
J. Han, J. Zhong, W. Wei, Y. Wang, Y. Huang, P. Yang, S. Purohit, Z. Dong, M.-H. Wang, J.-X. She, et al.
Extracellular High-Mobility Group Box 1 Acts as an Innate Immune Mediator to Enhance Autoimmune Progression and Diabetes Onset in NOD Mice
Diabetes, August 1, 2008; 57(8): 2118 - 2127.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A Kuhn and M Bijl
Pathogenesis of cutaneous lupus erythematosus
Lupus, May 1, 2008; 17(5): 389 - 393.
[Abstract] [PDF]